Respiratory Innovation Summit

Program Agenda

Hyatt Regency Orlando
9801 International Drive
Orlando, FL 32819

Friday, May 15 & Saturday, May 16

250516 181646 DK 2

Friday, May 15

11:30 a.m.Registration Desk Opens - Poster Set Up and Networking Available
12:00 p.m.

Breakout Sessions (60-minute blocks in small groups- Limited to 20 seats per session)

  • VC Pitch 101 – Niall O’Donnell, PhD, MA, MBA - Managing Director, RiverVest
  • Behind the Protocol: Key Operational Insights from Clinical Trial Execution – Doreen Miao, Vice President, Marketing & Strategic Development, THORASYS
  • Talking to Industry 101 – Maria Artunduaga, MD, MPH, MTM, Founder and CEO, Samay Health
  • Recruiting Patients for Trials (Patient Advocacy) – Teresa Barnes, Chief Executive Warrior, PF Warriors
  • Logistics in Early Decision Making & Operations – Shane Krauss, Director of Strategy, Strados Labs, Inc.
  • Pre-Clinical to Phase 1 Transition – Jason Kirkness, PhD, ATSF, SMSBiotech
  • How Imaging AI is Changing the Landscape of Pharma Clinical Trials - Todd Johnson, Chief Technology Officer and Josh Schirm, Senior Director, Clinical Development from VidaLung AI
4:00 p.m.Networking Session
5:00 p.m.Networking Reception – Posters Available
6:00 p.m.

Co-Chairs’ Welcoming Comments

  • Craig Conoscenti, MD, ATSF, Senior Vice President, Avalyn Pharma, Inc.
  • Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
6:10 p.m.Visionary Sponsor Address- Presented by Boehringer Ingelheim Pharmaceuticals, Inc.
6:40 p.m.

Opening Showcase – Welcome to Innovation

  • Moderator Josh Fessel, MD, PhD, ATSF
  • Edesa Biotech - Par Nijhawan MD, FRCPC, AGAF, Chief Executive Officer
  • fluidIQ - Teresa Barnes, President and Co-founder
  • Inhalon Biopharma, Inc. - John Whelan, Chief Executive Officer
  • Lung Games International Inc. - Nancy Lum-Wilson B.ScPhm, MBA, Chief Executive Officer
  • TidalSense - Leeran Talker, Machine Learning Engineering Manager
  • Moderator TBD
7:10 p.m.Networking Reception and Poster Viewing
9:00 p.m.Adjourn

Saturday, May 16

7:15 a.m.Continental Breakfast – Posters Available
8:00 a.m.

Welcome from the ATS President

  • Raed A. Dweik, MD, MBA, ATSF
8:10 a.m.

Co-Chair Address: State of Innovation and Investment

  • Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
  • Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
8:30 a.m.

Showcase One: Breakthroughs in Critical Care

  • Moderator: TBD
  • GEn1E Lifesciences Inc. - Ritu Lal Ph.D., M.S. (Management), CEO and Co-founder
  • Herald Therapeutics - David H Ingbar MD Professor (UMN), Chief Scientific Officer
  • Iff Technologies - Samarth Sandeep Chief Executive Officer
  • NuvOx Therapeutics Inc. - Rong Wang President and Chief Executive Officer
  • Tessara Bio - Jahar Bhattacharya Scientific Co-Founder & Research Lead
9:00 a.m.

Panel: Investor Discussion

  • Moderator: TBD
9:45 a.m.Networking Break – Posters Available
10:15 a.m.

Showcase Two: Reimagining Chronic Respiratory Care

  • Moderator: TBD
  • Altesa BioSciences, Inc. - Brett P. Giroir MD, Chief Executive Officer
  • CareCentra Inc. - Vasant Kumar Ramaswamy MBA, Founder & Chief Executive Officer
  • Kymera Therapeutics - Michael Feldman MD, PhD Executive Medical Director
  • Noze Inc. - Karim Aly, Chief Executive Officer
  • SMSbiotech - Abdulkader Rahmo, Chief Scientific Officer, Founder
10:45 a.m.

Smarter Signals: How Innovative Endpoints Are Changing the Drug Development Pathway

  • Moderator: Doreen Miao, Vice President, Marketing & Strategic Development, THORASYS
  • Adam LaPrad, PhD, Chief Technology Officer, ZephyRX
  • Bina Cho, Medical Lead, Sanofi
  • Glenn Crater, MD, Chief Medical Officer, Innospera Pharma
  • Jan De Backer, PhD, Chief Executive Officer, Fluidda
11:30 a.m.

Showcase Three: Cracking the Code of Lung Fibrosis

  • Moderator: TBD
  • Calluna Pharma - Mark Gaffney, Chief Executive Officer
  • Duke Clinical Research Institute (DCRI) - Scott Palmer, MD, MHS Professor
  • MannKind Corporation - Wassim Fares, MD, MSc, SVP, Orphan Lung Therapeutic Area Head
  • Polarean - Alex Dusek Chief Business Officer
  • Sunterra Bio Inc. - Michael Hy, Founder, Chief Executive Officer
12:00 p.m.Lunch – Posters Available
1:00 p.m.Panel: Business Development
1:45 p.m.

Showcase Four: Technology Transforming Respiratory Science

  • Moderator: TBD
  • Cincinnati Children's Hospital - Qiwei Xiao, PhD Research Faculty
  • Lungpacer Medical - Doug Evans, Chief Executive Officer
  • O2matic - Marie-Louise Little, Chief Executive Officer
  • Qnovia, Inc. - Mario Danek, Founder, Chief Executive Officer
  • Synchrony Medical - Anat Shani, Chief Executive Officer
2:30 p.m.Networking Break – Posters Available
3:00 p.m.

Showcase Five: The Emerging Science of Lung Disease

  • Moderator: Charles Powell, MD, MBA, Division Chief, Icahn School of Medicine
  • Eupnoos - Deepak Kotak MD, Chief Medical Officer
  • Open Source Imaging Consortium (OSIC) - Elizabeth Estes, Executive Director
  • Rabble Health Inc. - Aubrey Kelly Founder, Chief Executive Officer
  • ReCode Therapeutics - John Matthews, MBBS, MRCP, PhD, Chief Medical Officer
  • RNATICS - Klaus F. Rabe, Director of Airway Research Center North (ARCN)
3:30 p.m.

RIS Featured Success Story

  • Insilico Medicine
3:45 p.m.

Showcase Six: The Future of Lung Health

  • Moderator: TBD
  • Alveolus Bio Inc. - Ahmed Abdelgawad PhD, Research Scientist
  • Synapse Biomedical Inc. - Raymond Onders MD, Chair of Surgical Innovation
  • BioNAV Environmental Health – Robert Freeman, Founder, Chief Executive Officer
  • TrilliumBiO - Aamir Ali, MD, Chief Medical Officer
  • Vicore Pharma – Ahmed Mousa, Chief Executive Officer
  • Generate Biomedicines - Amit Parulekar MD, MS, ATSF, Senior Director, Clinical Development
4:30 p.m.

Closing Remarks and Sponsor Recognition

  • Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
  • Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
4:45 p.m.Networking Reception – Posters Available
6:00 p.m.Adjourn